FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/12/099892 [Registered on: 29/12/2025] Trial Registered Prospectively
Last Modified On: 29/12/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   Evaluate the Efficacy of Kapithashtak Churna in the Management of Tundikeri w.s.r to Tonsillitis 
Scientific Title of Study   An Open-Label Randomized Controlled Clinical Trial to Evaluate the Efficacy of Kapithashtak Churna in the Management of Tundikeri w.s.r. to Tonsillitis 
Trial Acronym  Nil  
Secondary IDs if Any  
Secondary ID  Identifier 
Nil   NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Vijayant Bhardwaj  
Designation  HOD Professor PG Department of Shalakya Tantra  
Affiliation  Rajiv Gandhi Govt. Post Graduate Ayurvedic College & Hospital, Paprola, Kangra, H.P. 176115, India  
Address  PG Department of Shalakya Tantra, Rajiv Gandhi Govt. Post Graduate Ayurvedic College & Hospital, Paprola, Kangra

Kangra
HIMACHAL PRADESH
176115
India 
Phone  9418017568  
Fax    
Email  bhardwajvijayant@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Vijayant Bhardwaj  
Designation  HOD Professor PG Department of Shalakya Tantra  
Affiliation  Rajiv Gandhi Govt. Post Graduate Ayurvedic College & Hospital, Paprola, Kangra, H.P. 176115, India  
Address  PG Department of Shalakya Tantra, Rajiv Gandhi Govt. Post Graduate Ayurvedic College & Hospital, Paprola, Kangra

Kangra
HIMACHAL PRADESH
176115
India 
Phone  9418017568  
Fax    
Email  bhardwajvijayant@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Akanksha Sharma 
Designation  PG Scholar  
Affiliation  Rajiv Gandhi Govt. Post Graduate Ayurvedic College & Hospital, Paprola, Kangra, H.P. 176115, India  
Address  PG Department of Shalakya Tantra, Rajiv Gandhi Govt. Post Graduate Ayurvedic College & Hospital, Paprola, Kangra

Kangra
HIMACHAL PRADESH
176115
India 
Phone  8278797044  
Fax    
Email  akankshasharma1612001@gmail.com  
 
Source of Monetary or Material Support  
Charak Pharmacy Rajiv Gandhi Govt Post Graduate Ayurvedic College and Hospital, Paprola, Kangra, H.P. 
 
Primary Sponsor  
Name  Rajiv Gandhi Govt Post Graduate Ayurvedic College and Hospital, Paprola 
Address  Rajiv Gandhi Govt Post Graduate Ayurvedic College and Hospital, Paprola, Distt. Kangra, H.P. 176115, India 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Vijayant Bhardwaj   Rajiv Gandhi Government Post Graduate Ayurvedic College and Hospital, Paprola  OPD No. 201, Department of Shalakya Tantra, Rajiv Gandhi Government Post Graduate Ayurvedic College and Hospital, Paprola, Distt. Kangra,H.P.,176115 India Kangra HIMACHAL PRADESH
Kangra
HIMACHAL PRADESH 
9418017568

bhardwajvijayant@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee(Human) Rajiv Gandhi Govt. Post Graduate Ayurvedic College and Hospital, Paprola, Distt. Kangra, H.P. 176115 India  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:B950||Streptococcus, group A, as the cause of diseases classified elsewhere. Ayurveda Condition: TUNDIKERI,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmDrugClassical(1) Medicine Name: Kapithashtak Churna, Reference: Sahastra yoga churna prakrana , Route: Oral, Dosage Form: Churna/ Powder, Dose: 3(g), Frequency: bd, Bhaishajya Kal: Adhobhakta, Duration: 15 Days, anupAna/sahapAna: Yes(details: Luke warm water), Additional Information: -
2Comparator Arm (Non Ayurveda)-Amoxicillin with clavulanic acid 625 mg / 12 hourly
 
Inclusion Criteria  
Age From  5.00 Year(s)
Age To  40.00 Year(s)
Gender  Both 
Details  Patients above 5 years & up to 40 years of age will be selected.
Patients who voluntarily give consent to participate in the study, or in case of children, consent given by parents/ guardians.
Patients exhibiting signs and symptoms of Tundikeri irrespective of gender. 
 
ExclusionCriteria 
Details  Known allergy or hypersensitivity to Amoxicillin & Clavulanic Acid.
Patients with complications of Tonsillitis.
Patients with Malignancies, Diabetes Mellitus & Hypertension.
Immunocompromised patients.
Patients with congenital deformities.
Pregnant & lactating mothers.
Individuals unwilling to participate in the study. 
 
Method of Generating Random Sequence   Other 
Method of Concealment   Other 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Relief in sign and symptoms of Tonsillitis such as congestion, no. of follicles, dysphagia, sore throat etc.  15 days  
 
Secondary Outcome  
Outcome  TimePoints 
To study the effect of Kapithashtak Churna in the improvement of Tonsillitis sign & symptoms such as congestion , size of tonsil, dysphagia, sore throat etc.  15 days 
 
Target Sample Size   Total Sample Size="30"
Sample Size from India="30" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   18/02/2026 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

I would like to publish my research work after completion of the trial as soon as possible. Patients

will be selected from OPD/IPD of RGGPG Ayurvedic College and Hospital, Paprola. 2 groups with

15 patients each will be registered as assessed to evaluate the effect of Kapithashtak Churna in the management of Tundikeri w.s.r. Tonsillitis.

 
Close